SUBSEQUENT EVENTS (Details) - USD ($)		1 Months Ended				9 Months Ended
SUBSEQUENT EVENTS (Details) - USD ($)	Jul. 19, 2017	Jul. 31, 2017	Jul. 31, 2016	Jun. 27, 2016	Apr. 30, 2016	Jul. 31, 2015	Apr. 01, 2016
Common Stock [Member]
Subsequent Event [Line Items]
Proceeds from private placement, shares						30,000,000
Subsequent Event [Member] \| Common Stock [Member]
Subsequent Event [Line Items]
Proceeds from private placement		$ 38,329			$ 38,329
Proceeds from private placement, shares		250,000			250,000
Subsequent Event [Member] \| Humavox [Member]
Subsequent Event [Line Items]
Percentage of interest purchased in acquisition				100.00%
Total purchase price				$ 16,000,000
Percentage of Company's common stock offered as consideration for acquisition				50.00%
Period of unconditional installments				24 months
Termination date for business acquisition agreement			Jul. 29, 2016
Subsequent Event [Member] \| Humavox [Member] \| Warrants and options [Member]
Subsequent Event [Line Items]
Percentage of interest purchased in acquisition				100.00%
Subsequent Event [Member] \| Humavox [Member] \| First installment amount [Member]
Subsequent Event [Line Items]
Total purchase price				$ 5,500,000
Subsequent Event [Member] \| Medical technology business [Member] \| Scenario, Forecast [Member]
Subsequent Event [Line Items]
Consideration owed for due diligence expenditures	$ 100,000
Consideration owed for additional due diligence expenditures	100,000
Common stock issuable as consideration for business acquisition at an issue price of USD$0.22	$ 2,500,000
Common stock issuance price per share	$ 0.22
Common stock issuable as consideration at issue price of USD$0.22 subject to the Sellers achieving sales revenue of USD$100,000 within twelve months after the first anniversary of Completion	$ 2,500,000
Common stock issuable as consideration at the issue price of USD$0.22, subject to the Sellers achieving sales revenue of USD$1,000,000 within twelve months after the first anniversary of Completion	$ 2,500,000
Issuance price per share for each milestone achieved	$ 0.22
Required capital to be raised by Company as part of acquisition agreement and as a condition to completion	$ 2,500,000
Subsequent Event [Member] \| Medical technology business [Member] \| Scenario, Forecast [Member] \| Maximum [Member]
Subsequent Event [Line Items]
Purchase price	$ 7,500,000
Subsequent Event [Member] \| PayItSimple [Member]
Subsequent Event [Line Items]
Investment amount							$ 15,000,000
Percentage purchase of interest							30.00%
Termination date for business acquisition agreement					Apr. 06, 2016
Subsequent Event [Member] \| PayItSimple [Member] \| Total Interest Holding [Member]
Subsequent Event [Line Items]
Percentage purchase of interest							40.00%
Subsequent Event [Member] \| PayItSimple [Member] \| Additional Investment [Member]
Subsequent Event [Line Items]
Investment amount							$ 7,500,000
Percentage purchase of interest							10.00%

Aurum, Inc. 10-Q